At Platelet BioGenesis we have designed, built, and patented a microfluidic-based bioreactor that mimics human bone marrow to produce human platelets. Platelets are the 'band-aids' of the bloodstream, responsible for clot formation and blood vessel repair. Over 2 million Americans receive platelet transfusions every year and the current supply of donor-platelets is both risky and limited. Creating a safer and unlimited alternative allows us to fundamentally disrupt a $2B market.

2014 Boston Finalist